Aarey Drugs

{
  "main_header": {
    "sid": 933527,
    "name": "Aarey Drugs",
    "stock_name": "Aarey Drugs",
    "full_name": "Aarey Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/aarey-drugs",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "95.71",
    "chg": -4.27,
    "chgp": "-4.27%",
    "dir": -1,
    "prev_price": "99.98",
    "mcapval": "303.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524412,
    "symbol": "AAREYDRUGS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE198H01019",
    "curr_date": "Sep 10, 03:30 PM",
    "curr_time": "05:03 AM",
    "last_traded_at": "Sep 10, 03:30 PM IST",
    "bse_nse_vol": "1.08 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 10, 2026",
    "traded_date_str": "2026 09 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarey-drugs-933527-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Aarey Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 101.11",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-new-52-week-high-at-rs10111-4188919",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AareyDrugsPharm_priceRelatedfactors_4188919.png",
        "date": "2026-09-10 09:50:59",
        "description": "Surging past the Rs 100 mark for the first time in 52 weeks, Aarey Drugs & Pharmaceuticals Ltd has demonstrated remarkable price momentum, climbing from a low of Rs 50.40 to Rs 101.11 in the past year. This 36.68% gain stands in stark contrast to the Sensex’s 8.15% decline over the same period, underscoring the stock’s resilience amid a broadly challenging market environment."
      },
      {
        "title": "Aarey Drugs Surges 12.21%: Four Key Drivers Behind the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-surges-1221-four-key-drivers-behind-the-rally-4174415",
        "imagepath": "",
        "date": "2026-08-29 15:00:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>24 Aug:</strong> Stock opens strong at ₹80.34 (+1.11%) amid weak Sensex</p>\n                    <p><strong>25 Aug:</strong> Valuation upgrade signals renewed price attractiveness</p>\n                    <p><strong>26 Aug:</strong> Hits upper circuit limit, closing at ₹80.88 (+5.00%)</p>\n                    <p><strong>27 Aug:</strong> Consecutive upper circuit hit, closes at ₹84.92 (+5.00%)</p>\n                    <p><strong>28 Aug:</strong> Third straight upper circuit, closes at ₹89.16 (+4.99%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.79.46</div>..."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-upper-circuit-amid-robust-buying-pressure-4173676",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AareyDrugsPharm_stocks_hitting_upper_circuit_4173676.png",
        "date": "2026-08-28 14:00:10",
        "description": "At Rs 89.01, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 4.99% on 28 Aug 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-ltd-is-rated-sell-4173408",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AareyDrugsPharm_mojoScore_4173408.png",
        "date": "2026-08-28 10:10:23",
        "description": "Aarey Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Locks at Upper Circuit With 4.9% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-4171363",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AareyDrugsPharm_stocks_hitting_upper_circuit_4171363.png",
        "date": "2026-08-27 10:00:36",
        "description": "At Rs 84.78, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 4.9% on 27 Aug 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-4170237",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AareyDrugsPharm_stocks_hitting_upper_circuit_4170237.png",
        "date": "2026-08-26 11:00:12",
        "description": "At Rs 80.75, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 5% on 26 Aug 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4168223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AareyDrugsPharm_valuationdot_4168223.png",
        "date": "2026-08-25 08:01:26",
        "description": "Aarey Drugs & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite a downgrade in its overall Mojo Grade to Sell. This nuanced change reflects evolving market perceptions amid mixed financial metrics and a challenging industry backdrop, offering investors a fresh perspective on the stock’s price attractiveness relative to peers and historical benchmarks."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4158588",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AareyDrugsPharm_valuationdot_4158588.png",
        "date": "2026-08-18 08:01:35",
        "description": "Aarey Drugs & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive rating, despite lingering concerns over profitability and market positioning. This micro-cap pharmaceutical player’s recent price movements and valuation metrics warrant a closer examination to understand the evolving price attractiveness and what it means for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-ltd-is-rated-sell-4157928",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AareyDrugsPharm_mojoScore_4157928.png",
        "date": "2026-08-17 10:10:03",
        "description": "Aarey Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 617,
    "sid": "933527",
    "stock_news_url": "https://www.marketsmojo.com/news/aarey-drugs-pharmaceuticals-933527"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 13 Dec 18",
          "dt": "2018-12-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>1:5</strong> bonus issue, ex-date: 25 Jun 12",
          "dt": "2012-06-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>2:1</strong> rights issue, ex-date: 19 Jan 12",
          "dt": "2012-01-19",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Aarey Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 101.11

2026-09-10 09:50:59

Surging past the Rs 100 mark for the first time in 52 weeks, Aarey Drugs & Pharmaceuticals Ltd has demonstrated remarkable price momentum, climbing from a low of Rs 50.40 to Rs 101.11 in the past year. This 36.68% gain stands in stark contrast to the Sensex’s 8.15% decline over the same period, underscoring the stock’s resilience amid a broadly challenging market environment.

Read full news article

Aarey Drugs Surges 12.21%: Four Key Drivers Behind the Rally

2026-08-29 15:00:07

Key Events This Week

24 Aug: Stock opens strong at ₹80.34 (+1.11%) amid weak Sensex

25 Aug: Valuation upgrade signals renewed price attractiveness

26 Aug: Hits upper circuit limit, closing at ₹80.88 (+5.00%)

27 Aug: Consecutive upper circuit hit, closes at ₹84.92 (+5.00%)

28 Aug: Third straight upper circuit, closes at ₹89.16 (+4.99%)

Week Open

Rs.79.46

...

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-08-28 14:00:10

At Rs 89.01, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 4.99% on 28 Aug 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd is Rated Sell

2026-08-28 10:10:23

Aarey Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Locks at Upper Circuit With 4.9% Gain — Buyers Queue, Sellers Absent

2026-08-27 10:00:36

At Rs 84.78, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 4.9% on 27 Aug 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-08-26 11:00:12

At Rs 80.75, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 5% on 26 Aug 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness

2026-08-25 08:01:26

Aarey Drugs & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite a downgrade in its overall Mojo Grade to Sell. This nuanced change reflects evolving market perceptions amid mixed financial metrics and a challenging industry backdrop, offering investors a fresh perspective on the stock’s price attractiveness relative to peers and historical benchmarks.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness

2026-08-18 08:01:35

Aarey Drugs & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive rating, despite lingering concerns over profitability and market positioning. This micro-cap pharmaceutical player’s recent price movements and valuation metrics warrant a closer examination to understand the evolving price attractiveness and what it means for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd is Rated Sell

2026-08-17 10:10:03

Aarey Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News